Clinical Trial Update: S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gemcitabine for recurrent bladder cancer that did not respond to BCG; trial completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-12-18